Article Title,Year,Volume,Issue,Page Range,Author
Has the time come to abandon efavirenz for first-line antiretroviral therapy?,2014,69,7,1742-1747,Raffi
Determinants of the activity of beta-lactamase inhibitor combinations,1993,31 Suppl A,,9-21,Livermore